SCHEMBL10030022

SCHEMBL10030022

c1ccc(-c2ccc3c(-c4ccc(-c5cccnc5)cc4)c4ccccc4c(-c4ccc(-c5cccnc5)cc4)c3c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 5/20 0.53
CYP11B2 P19099 5/20 0.53
CYP19A1 P11511 3/20 0.53
CYP17A1 P05093 1/20 0.53
CYP2A6 P11509 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
ALDH1A1 P00352 1/20 0.50
DHODH Q02127 1/20 0.48
MKNK1 Q9BUB5 3/20 0.47
MKNK2 Q9HBH9 3/20 0.47
LMNA P02545 1/20 0.47
RAF1 P04049 1/20 0.47
MAPK1 P28482 1/20 0.47
HIF1A Q16665 1/20 0.47
CHEK1 O14757 2/20 0.47
AURKA O14965 1/20 0.47
DAPK3 O43293 1/20 0.47
JAK2 O60674 1/20 0.47
PRKD3 O94806 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10030052 1.00 CYP11B1 (0.53) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6
SCHEMBL15977643 1.00 CYP11B1 (0.53) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6
SCHEMBL15977675 1.00 CYP11B1 (0.53) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6
SCHEMBL10300954 0.98 CYP11B1 (0.54) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6
SCHEMBL13004544 0.98 CYP11B2 (0.54) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6
SCHEMBL10030033 0.97 CYP11B1 (0.50) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6
SCHEMBL10030045 0.97 CYP11B1 (0.50) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6
SCHEMBL13158589 0.97 CYP11B1 (0.49) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6
SCHEMBL13145566 0.97 CYP11B1 (0.49) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6
SCHEMBL13145330 0.97 CYP11B1 (0.49) CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11342511-B2 Azoline ring-containing compound, electron transport/injection layer material containing the same, and organic electroluminescent element using the same SK MATERIALS JNC CO., LTD. (KR) 2022-05-24 US disclosed
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
US-10693107-B2 Organic electroluminescence device having RGB pixel areas BEIJING VISIONOX TECHNOLOGY CO., LTD. (CN) 2020-06-23 US disclosed
US-20180212156-A1 AZOLINE RING-CONTAINING COMPOUND, ELECTRON TRANSPORT/INJECTION LAYER MATERIAL CONTAINING THE SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME JNC CORPORATION (JP) 2018-07-26 US disclosed
US-20180212156-A1 AZOLINE RING-CONTAINING COMPOUND, ELECTRON TRANSPORT/INJECTION LAYER MATERIAL CONTAINING THE SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME JNC CORPORATION (JP) 2018-07-26 US disclosed
US-9954169-B2 Organic EL display and method of manufacturing the same JOLED INC. (JP) 2018-04-24 US disclosed
US-9954169-B2 Organic EL display and method of manufacturing the same JOLED INC. (JP) 2018-04-24 US disclosed
US-9860960-B2 Organic EL display device and method for production of the same JOLED INC. (JP) 2018-01-02 US disclosed
US-20170373276-A1 ORGANIC ELECTROLUMINESCENCE DEVICE HAVING RGB PIXEL AREAS BEIJING VISIONOX TECHNOLOGY CO., LTD. (CN) 2017-12-28 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-8823255-B2 Organic el display device and method of manufacturing the same SONY CORPORATION (JP) 2014-09-02 US disclosed
US-8823255-B2 Organic el display device and method of manufacturing the same SONY CORPORATION (JP) 2014-09-02 US disclosed
US-20130183781-A1 ORGANIC EL DISPLAY AND METHOD OF MANUFACTURING THE SAME SONY CORPORATION (JP) 2013-07-18 US disclosed
US-20130183781-A1 ORGANIC EL DISPLAY AND METHOD OF MANUFACTURING THE SAME SONY CORPORATION (JP) 2013-07-18 US disclosed
US-20120187386-A1 ORGANIC ELECTRO LUMINESCENCE DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME SONY CORPORATION (JP) 2012-07-26 US disclosed
US-20120187386-A1 ORGANIC ELECTRO LUMINESCENCE DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME SONY CORPORATION (JP) 2012-07-26 US disclosed
US-20120112173-A1 ORGANIC EL DISPLAY DEVICE AND METHOD FOR PRODUCTION OF THE SAME SONY CORPORATION (JP) 2012-05-10 US disclosed
US-20120112173-A1 ORGANIC EL DISPLAY DEVICE AND METHOD FOR PRODUCTION OF THE SAME SONY CORPORATION (JP) 2012-05-10 US disclosed
US-20110315963-A1 ORGANIC EL DISPLAY AND METHOD OF MANUFACTURING THE SAME SONY CORPORATION (JP) 2011-12-29 US disclosed
US-20110315963-A1 ORGANIC EL DISPLAY AND METHOD OF MANUFACTURING THE SAME SONY CORPORATION (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 CYP11B1 759/4885CYP11B2 474/4885CYP19A1 1341/4885
US-11342511-B2 Azoline ring-containing compound, electron transport/injection layer material containing the same, and organic electroluminescent element using the same SLC7A5, EML4, ARNT CYP11B1 82/4885CYP11B2 101/4885CYP19A1 157/4885
US-10693107-B2 Organic electroluminescence device having RGB pixel areas RHEB, CYBA, RUVBL2 CYP11B1 2174/4885CYP11B2 2374/4885CYP19A1 3419/4885
US-20180212156-A1 AZOLINE RING-CONTAINING COMPOUND, ELECTRON TRANSPORT/INJECTION LAYER MATERIAL CONTAINING THE SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME SLC7A5, EML4, ARNT CYP11B1 82/4885CYP11B2 101/4885CYP19A1 157/4885
US-20170373276-A1 ORGANIC ELECTROLUMINESCENCE DEVICE HAVING RGB PIXEL AREAS RUVBL2, RHEB, RUVBL1 CYP11B1 2233/4885CYP11B2 2361/4885CYP19A1 3903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.